Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Acta Crystallographica. Section F, Structural Biology Communications|March 19, 2014
Crystallization and preliminary X-ray crystallographic analysis of the extracellular domain of LePRK2 from Lycopersicon esculentumAnbi Xu, Laiqiang Huang
Acta Crystallographica. Section F, Structural Biology Communications|March 19, 2014
Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of the LRR domain of the LePRK1 receptor-like kinase from tomatoAnbi Xu, Laiqiang Huang
Cellular Signalling|September 10, 2013
WITHDRAWN: TRIP-1 interacts with ezrin to regulate ezrin phosphorylation, cell protrusion formation and cell migrationHongling Zhang, Jun Wan, Laiqiang Huang
Oncology Letters|December 21, 2012
Adenovirus-mediated combined anti-angiogenic and pro-apoptotic gene therapy enhances antitumor efficacy in hepatocellular carcinomaFei Yan, Yi Zheng, Laiqiang Huang
Journal of Materials Chemistry. B|April 8, 2020
Systematic investigation of intracellular trafficking behavior of one-dimensional alumina nanotubesXiangyu Sun, Lijuan Jiang, Chunnan Wang, et al.
Journal of Microbiology (Seoul, Korea)|December 25, 2008
Enhancement of immunotherapeutic effects of HPV16E7 on cervical cancer by fusion with CTLA4 extracellular regionYi Zheng, Yijuan Zhang, Yuandong Ma, et al.
Biosensors|October 27, 2022
Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109Albert Yu, Xiaoyong Dai, Zixian Wang, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
BRG1, the ATPase subunit of SWI/SNF chromatin remodeling complex, interacts with HDAC2 to modulate telomerase expression in human cancer cellsShu Wu, Yuanlong Ge, Laiqiang Huang, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 28, 2022
Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expressionKun Wang, Xiaoyong Dai, Albert Yu, et al.
Biosensors|February 24, 2022
Recent Advances of Mesoporous Silica as a Platform for Cancer ImmunotherapyAlbert Yu, Xiaoyong Dai, Zixian Wang, et al.
Pageof 9